— Know what they know.
Not Investment Advice

MRRCF OTC

Wayland Group Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +900.0% 1Y: +0.0% 3Y: +900.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $2121 mcap · 197M float · 0.0006% daily turnover

Income Trends

Revenue
$2M -19.0% ▼
Gross Profit
-$4M -176.4% ▼
Operating Income
-$21M -273.7% ▼
Net Income
-$52M -724.5% ▼
EPS (Diluted)
$-0.75 -341.2% ▼
EBITDA
-$50M -817.0% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2015FY2016FY2017
Revenue$0$3M$2M
YoY Growth+0.0%+0.0%-19.0%
Cost of Revenue$0$4M$6M
Gross Profit$0-$1M-$4M
Gross Margin—-45.4%-154.9%
R&D Expenses$0$0$0
SG&A Expenses$43K$4M$17M
Operating Expenses$43K$4M$17M
Operating Income-$43K-$6M-$21M
Operating Margin—-186.2%-858.7%
Interest Expense$36$340K$37
Income Before Tax-$73K-$6M-$52M
Tax Expense$0-$3$5
Net Income-$73K-$6M-$52M
Net Margin—-204.3%-2079.4%
EPS (Diluted)$-0.01$-0.17$-0.75
EBITDA-$43K-$5M-$50M
Shares Outstanding6M37M69M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms